TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Unilabs Laboratoriemedisin AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
108,071
|
129,319
|
115,268 |
Financial expenses |
2,092
|
1,249
|
1,300 |
Earnings before taxes |
2,971
|
6,761
|
16,068 |
Total assets |
80,528
|
101,363
|
69,655 |
Current assets |
32,183
|
45,380
|
37,494 |
Current liabilities |
29,598
|
35,413
|
39,188 |
Equity capital |
25,334
|
24,197
|
17,899 |
- share capital |
253
|
267
|
253 |
Employees (average) | 79 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
31.5%
|
23.9%
|
25.7% |
Turnover per employee | 1,637 | ||
Profit as a percentage of turnover |
2.7%
|
5.2%
|
13.9% |
Return on assets (ROA) |
6.3%
|
7.9%
|
24.9% |
Current ratio |
108.7%
|
128.1%
|
95.7% |
Return on equity (ROE) |
11.7%
|
27.9%
|
89.8% |
Change turnover |
-14,456
|
7,840
|
4,297 |
Change turnover % |
-12%
|
6%
|
4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.